|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
|
|---|---|---|---|
| Revenue | |||
| Nonrelated Party | |||
| Related Party | |||
| Total revenue | |||
| Cost of sales | |||
| Gross profit (loss) | |||
| Research and development | |||
| Selling, general and administrative | |||
| Disposal, restructuring and other operating expenses, net | |||
| Total operating expenses | |||
| Operating income (loss) | |||
| Income (loss) from equity investments, net | |||
| Interest income, net | |||
| Other non-operating income (loss), net | |||
| Income (loss) before income taxes | |||
| Income tax benefit (expense) | |||
| Net income (loss) from continuing operations | |||
| Loss from discontinued operations before income taxes | |||
| Income tax benefit (expense) from discontinued operations | |||
| Net loss from discontinued operations | |||
| Net income (loss) | |||
| Net income (loss) per share attributable to ordinary shareholders | |||
| Basic (in USD per share) | |||
| Net loss from discontinued operation (in USD per share) | |||
| Diluted (in USD per share) | |||
| Weighted average ordinary shares outstanding | |||
| Basic (in shares) | |||
| Diluted (in shares) |
Loading...
